Danielle de Jong
Overview
Explore the profile of Danielle de Jong including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
71
Citations
1404
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Pierneef L, van Hooij A, de Jong D, Tjon Kon Fat E, van Meijgaarden K, Petruccioli E, et al.
iScience
. 2023 Jan;
26(1):105873.
PMID: 36590898
Diagnostic services for tuberculosis (TB) are not sufficiently accessible in low-resource settings, where most cases occur, which was aggravated by the COVID-19 pandemic. Early diagnosis of pulmonary TB can reduce...
12.
Heijkants R, Teunisse A, de Jong D, Glinkina K, Mei H, Kielbasa S, et al.
Cancers (Basel)
. 2022 Sep;
14(18).
PMID: 36139642
The tumor suppressor protein p53 has an important role in cell-fate determination. In cancer cells, the activity of p53 is frequently repressed by high levels of MDMX and/or MDM2. MDM2...
13.
Quiroga-Artigas G, de Jong D, Schnitzler C
Open Biol
. 2022 Sep;
12(9):220120.
PMID: 36069077
() is a vertebrate gene preferentially expressed in stem and cancer cells, which acts to regulate cell cycle progression, genome stability and ribosome biogenesis. and its paralogous gene, (), arose...
14.
Zhou Z, Pena M, van Hooij A, Pierneef L, de Jong D, Stevenson R, et al.
Front Microbiol
. 2021 Nov;
12:763289.
PMID: 34777319
Leprosy is an infectious disease caused by with tropism for skin and peripheral nerves. Incessant transmission in endemic areas is still impeding elimination of leprosy. Although detection of infection remains...
15.
F Martins M, Loos N, Mucuk S, de Jong D, Lebre M, Rosing H, et al.
Mol Pharm
. 2021 Nov;
18(12):4371-4384.
PMID: 34730366
Niraparib (Zejula), a selective oral PARP1/2 inhibitor registered for ovarian, fallopian tube, and primary peritoneal cancer treatment, is under investigation for other malignancies, including brain tumors. We explored the impact...
16.
Lohberger B, Scheipl S, Heitzer E, Quehenberger F, de Jong D, Szuhai K, et al.
Sci Rep
. 2021 Jun;
11(1):12466.
PMID: 34127734
Chordomas are rare slow growing, malignant bone tumors of the axial skeleton with no approved medical treatment. As the majority of chordomas express cMET and its ligand, HGF, and crosstalks...
17.
van Hooij A, Tjon Kon Fat E, de Jong D, Khatun M, Soren S, Chowdhury A, et al.
iScience
. 2021 Jan;
24(1):102006.
PMID: 33490914
To end the decade-long, obstinately stagnant number of new leprosy cases, there is an urgent need for field-applicable diagnostic tools that detect infection with , leprosy's etiologic agent. Since immunity...
18.
van IJzendoorn D, Salvatori D, Cao X, van den Hil F, Briaire-de Bruijn I, de Jong D, et al.
Cell Rep Med
. 2020 Dec;
1(9):100153.
PMID: 33377124
Chromosomal translocations are prevalent among soft tissue tumors, including those of the vasculature such as pseudomyogenic hemangioendothelioma (PHE). PHE shows endothelial cell (EC) features and has a tumor-specific t(7;19)(q22;q13) SERPINE1-FOSB...
19.
van Dijk J, van Hooij A, Groot L, Geboers J, Moretti R, Verhard-Seymonsbergen E, et al.
Chembiochem
. 2020 Dec;
22(8):1487-1493.
PMID: 33332701
Point-of-care (POC) diagnostic tests for the rapid detection of individuals infected with Mycobacterium leprae, the causative pathogen of leprosy, represent efficient tools to guide therapeutic and prophylactic treatment strategies in...
20.
van Hooij A, Tio-Coma M, Verhard E, Khatun M, Alam K, Tjon Kon Fat E, et al.
Front Immunol
. 2020 Aug;
11:1811.
PMID: 32849645
Leprosy is a chronic infectious disease, caused by , that can lead to severe life-long disabilities. The transmission of is continuously ongoing as witnessed by the stable new case detection...